Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Cancer Therapy: Preclinical

In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target

Ada W.Y. Leung, Chansey J. Veinotte, Nicole Melong, Min Hee Oh, Kent Chen, Katey S.S. Enfield, Ian Backstrom, Corinna Warburton, Donald Yapp, Jason N. Berman, Marcel B. Bally and William W. Lockwood
Ada W.Y. Leung
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aleung@bccrc.ca
Chansey J. Veinotte
Department of Pediatrics, Dalhousie University/IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Melong
Department of Pediatrics, Dalhousie University/IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Hee Oh
Integrative Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kent Chen
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katey S.S. Enfield
Integrative Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Backstrom
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinna Warburton
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Yapp
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason N. Berman
Department of Pediatrics, Dalhousie University/IWK Health Centre, Halifax, Nova Scotia, Canada.Department of Microbiology & Immunology and Pathology, Life Sciences Research Institute, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel B. Bally
Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.Centre for Drug Research and Development, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William W. Lockwood
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.Integrative Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, British Columbia, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-17-0700 Published November 2017
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

Volume 23, Issue 21, pp. 6555-6566

DOI 
https://doi.org/10.1158/1078-0432.CCR-17-0700
PubMed 
28790117

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Received March 13, 2017
  • Revision received July 5, 2017
  • Accepted August 1, 2017
  • Published first August 8, 2017.

Article Versions

  • Previous version (August 8, 2017 - 06:37).
  • Previous version (September 27, 2017 - 07:10).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2017 American Association for Cancer Research.

Author Information

  1. Ada W.Y. Leung1,2,*,
  2. Chansey J. Veinotte3,
  3. Nicole Melong3,
  4. Min Hee Oh4,5,
  5. Kent Chen1,5,
  6. Katey S.S. Enfield4,
  7. Ian Backstrom1,
  8. Corinna Warburton1,
  9. Donald Yapp1,6,
  10. Jason N. Berman3,7,
  11. Marcel B. Bally1,2,6,8, and
  12. William W. Lockwood2,4,5
  1. 1Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
  2. 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  3. 3Department of Pediatrics, Dalhousie University/IWK Health Centre, Halifax, Nova Scotia, Canada.
  4. 4Integrative Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
  5. 5The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, British Columbia, Canada.
  6. 6Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  7. 7Department of Microbiology & Immunology and Pathology, Life Sciences Research Institute, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  8. 8Centre for Drug Research and Development, Vancouver, British Columbia, Canada.
  1. ↵*Corresponding Author:
    Ada Wai Yin Leung, 5.304 Experimental Therapeutics, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. Phone: 604-678-8000, ext. 7024; Fax: 604-675-8183; E-mail: aleung{at}bccrc.ca
View Full Text

PreviousNext
Back to top
Clinical Cancer Research: 23 (21)
November 2017
Volume 23, Issue 21
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
Citation Tools
In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target
Ada W.Y. Leung, Chansey J. Veinotte, Nicole Melong, Min Hee Oh, Kent Chen, Katey S.S. Enfield, Ian Backstrom, Corinna Warburton, Donald Yapp, Jason N. Berman, Marcel B. Bally and William W. Lockwood
Clin Cancer Res November 1 2017 (23) (21) 6555-6566; DOI: 10.1158/1078-0432.CCR-17-0700

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target
Ada W.Y. Leung, Chansey J. Veinotte, Nicole Melong, Min Hee Oh, Kent Chen, Katey S.S. Enfield, Ian Backstrom, Corinna Warburton, Donald Yapp, Jason N. Berman, Marcel B. Bally and William W. Lockwood
Clin Cancer Res November 1 2017 (23) (21) 6555-6566; DOI: 10.1158/1078-0432.CCR-17-0700
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Enhanced Delivery of SN38-TOA NPs in NBs
  • Radiotherapy with IDO1/PD-1 Blockade Treats Advanced GBM
  • TCRs against MCV T-antigens
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement